Discovery of Phenylacylpiperidine as Novel sEH Inhibitors through Scaffold Hopping of Natural Stilbene

Jing Ding, Min Zhen Zhu, Xiao Yu Du, Si Meng Liu, Hao Wang*, Xing Zhou Liu, Wei Song Xie, Hong Le Ma, Yue Feng*, Xin Hong Zhu*, Jian Hua Liang*

*此作品的通讯作者

科研成果: 期刊稿件文章同行评审

摘要

Despite the development of soluble epoxide hydrolase (sEH) inhibitors as a promising therapeutic approach, no drug candidate has successfully progressed beyond clinical phase II, highlighting the need for a novel chemotype with improved in vivo potency, pharmacokinetics and safety. In this study, we discovered a phenylacetylpiperidine-based compound, 77 (lab code: DJ-89; IC50: 0.51 nM), through strategic scaffold hopping from previously reported styrene-based sEH inhibitors. Resolving the cocrystal structure and mode-of-action studies revealed a distinct profile compared to well-known sEH inhibitors TPPU and EC5026 (IC50: 44, 19 nM). Notably, 77 demonstrated additional interactions with sEH compared to TPPU, and uniquely enhanced anti-inflammatory factors, including EET levels and IL-10, a capability not observed with EC5026. Moreover, 77 showed excellent pharmacokinetics and safety, positioning it as a promising candidate for treating both acute and chronic inflammatory diseases, including rheumatoid arthritis, leveraging phenylacylpiperidine scaffolds in sEH-targeted therapies.

源语言英语
页(从-至)8980-9013
页数34
期刊Journal of Medicinal Chemistry
68
8
DOI
出版状态已出版 - 24 4月 2025

指纹

探究 'Discovery of Phenylacylpiperidine as Novel sEH Inhibitors through Scaffold Hopping of Natural Stilbene' 的科研主题。它们共同构成独一无二的指纹。

引用此